Immunotherapy Weekly articles from December 2002

Immunotherapy Weekly archives from December 2002

Chronic stress can interfere with normal function of immune system.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Chronic stress not only makes people more vulnerable to catching illnesses but can also impair their immune system's ability to respond to its own anti-inflammatory signals that are triggered by certain...

How HIV outmaneuvers the immune system.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- T cells and antibody-producing B cells carry out immune defense against specific pathogens such as viruses. Antibodies and T cell receptors are highly diverse molecules that can recognize millions of...

Disease costs are driven by medications, work loss.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Pharmaceuticals and work loss are major driving forces in asthma's cost to society, according to a study presented at the American College of Chest Physicians'...

Herpes amplicon vectors used to develop vaccines against metastatic liver cancer.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Vaccines consisting of irradiated colon cancer cells that released granulocyte-macrophage colony-stimulating factor (GM-CSF), or GM-CSF along with the...

Interleukin-12 restores antigen-specific response to hepatitis B virus.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Interleukin-12 may be beneficial for restoring antigen-specific response in patients infected with hepatitis B virus (HBV). Researchers think weak...

New treatment strategy shows early promise.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A preliminary study reports that enhancing the body's innate immunity can improve symptoms of Crohn disease in 80% of patients with moderate to severe forms of the debilitating, inflammatory...

Dr. Barbara Seliger named to scientific advisory board.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced that Professor Dr. Barbara Seliger has joined the company's scientific advisory board. Seliger is professor of immunology and pathophysiology at the Johannes...

CDC: One in three adults has arthritis.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- The Arthritis Foundation has called for a new sense of urgency and resolve to address the pain, limitations and disability of arthritis based on alarming new numbers from the U.S. Centers for Disease...

Disease management program helps patients improve outcomes.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A new disease management program with a relatively lightweight resource arsenal seems to help asthma patient control their disease better, according to a study...

Low literacy is not to blame for medication noncompliance.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Although countless studies have proven that a combination of anti-inflammatory agents and short-acting medications to control acute asthmatic symptoms works,...

Rituximab effectively treats refractory systemic antibody-mediated conditions.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Manifestations of refractory systemic antibody-mediated autoimmune disorders were resolved in three patients treated with rituximab, according to a recent report. Rituximab is a chimeric monoclonal...

PRIMABioMed announces success of phase I trial for dendritic cell based therapy.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- PRIMABioMed, Ltd., the cancer and immunotherapy research and therapeutic development company, announced successful progress in the development of its Cancer Vac subsidiary's dendritic cell based therapy...

Study: Tumor regression occurs after injection of DNA complex.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- In a scientific article published this month, a group of research scientists with Genzyme Molecular Oncology (GZMO) report that immune-stimulating complexes made up of lipid and plasmid DNA produced...

Dendritic-cell based immunotherapy may have potential against brain tumors.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Neurologists in Japan report enhancement of antitumor immune responses in murine models of brain tumors by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12....

Candida-specific IgA antibodies may have limited natural protective activity.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A recent study investigated the role of humoral immunity induced by Candida albicans infection in protection against experimental vaginal candidiasis. "Protective host defense mechanisms against...

Donor and recipient strains affect CD8+ T cell-mediated rejection.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- "The effectiveness of anti-CD154 monoclonal antibodies in prolonging the survival of mouse allografts is dependent on the strain combination," say researchers who conducted a study on the "impact of...

Medix Biochemica licenses CEA antibody technology.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced that Medix Biochemica of Kauniainen, Finland, entered into a nonexclusive license agreement under Immunomedics' portfolio of carcinoembryonic antigen (CEA) patents....

Monoclonal antibodies reduce immunosuppression in GvHD case.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Duke University Medical Center pediatricians reported results of monoclonal antibody immunotherapy in a patient with steroid refractory chronic graft-versus-host disease. "In this case report we...

New method allows mass production of dendritic cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Large-scale production of dendritic cells is possible through the use of a cell selector followed by culture in a sterile-bag system, according to...

Company results for 2002 third quarter and 9-month period.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that total revenues increased 53% to $73 million in the 2002 third quarter and 43% to $466 million in the first 9 months of the year. Worldwide sales of Synagis,...

HspE7 partner reports third quarter 2002 financial results.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Stressgen Biotechnologies Corp. (SSB) reported financial results for the quarter and 9 months ended September 30, 2002. All amounts, unless specified otherwise, are in Canadian dollars. "This...

Soy protein component cross-reacts with caseins from cow's milk.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- According to immunologists in Argentina, "Soy-based formulas are the most employed cow's milk substitutes in the treatment of cow's milk allergy in our country. Since adverse reactions have been...

Patients' dendritic cells induce fewer virus-specific T helper cells.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Weak antiviral immune responses observed in patients with chronic hepatitis B virus infection may partly be due to insufficient T-cell stimulating capacities of dendritic cells, say researchers in...

Pharmaceutical group identifies new class of CpG oligonucleotides.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group, Inc., announced the identification of a novel class of its proprietary CpG oligo drug candidates, termed "C-Class" oligos. One member of this class, CpG 10101, strongly...

Antitumor effects induced by dendritic cell-based immunotherapy in animal model.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Researchers in Japan report positive results in their study of dendritic cell-based immunotherapy of pancreatic cancer in a hamster model. "Because the prognosis of patients with pancreatic cancer...

New data demonstrate safety and efficacy of leflunomide.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Two studies presented at the American College of Rheumatology (ACR) 66th annual meeting demonstrate the consistent efficacy and safety of Arava (leflunomide) in treating rheumatoid arthritis. The...

Drotrecogin alfa drug sustains long-term survival.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A genetically engineered drug - drotrecogin alfa (Xigris) - already proven to help patients survive the acute phase of severe sepsis also helps them remain alive...

Human monoclonal antibodies against Shiga toxin 1 developed.
December 4, 2002... 2002 DEC 4 - (NewsRx.com & NewsRx.net) -- Human monoclonal antibodies developed as immunotherapy against Shiga toxin 1 neutralized the toxin in vitro and prolonged survival of infected HuMAb-mice, report Tufts University researchers. ...

Cyclophilin B peptide fails in phase 1 lung cancer trial.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Phase 1 clinical trial results revealed that a cyclophilin B peptide vaccine was safe when given to lung cancer patients, but did not elicit a...

T-cell clones shrink tumors.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A preliminary clinical trial suggests that armies of T cells generated in the lab can be injected into patients to halt the spread of cancerous tumors. The study, conducted by Dr. Cassian Yee, a...

Elderly sensitized to cockroach allergens have more airway obstruction.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Cockroach (CR) allergens may play a significant role in urban asthma morbidity, particularly among the elderly. A study conducted at the New York University School of Medicine found that urban...

Full NAEPP guidelines available free.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- In order to provide timely information on priority asthma topics, the online version of the Journal of Allergy and Clinical Immunology (JACI) features free access to the full text of the National...

Tumor vaccine raises antigen-specific response in gastric cancer patients.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Medical collaborators in Japan and Sweden have completed a phase I trial of peptide-pulsed dendritic cells in gastric cancer patients. Scientists have...

Research: Tegaserod maleate safe and effective for IBS symptoms.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- New data published in Alimentary Pharmacology & Therapeutics demonstrate Zelnorm (tegaserod maleate) provides rapid relief for women suffering from the multiple symptoms of abdominal pain and...

Promising results reported for infliximab.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- New data from the IMPACT trial (infliximab multinational psoriatic arthritis controlled trial), assessing the efficacy and safety of Remicade (infliximab) in treating patients with psoriatic arthritis...

Company granted new patent for dermatological treatment.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 6,429,231 to Bradley. The patent, titled "Novel composition containing...

Tuberculin response higher in BCG-vaccinated children with allergic diseases.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Among bacillus Calmette-Guerin (BCG)-vaccinated children, those with allergies mount a higher response to tuberculin than those who are nonallergic, a recent study found. "The prevalence of...

University of British Columbia enters license agreement with biotech company.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- The University of British Columbia (UBC) and ARC Pharmaceuticals, Inc., announced that they have entered into an exclusive worldwide license agreement for the development and commercial sale of a class...

P38 MAP kinase inhibitor data presented at rheumatology meeting.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Scios, Inc., (SCIO) announced that preclinical study results indicate that SCIO-469, the company's first-generation oral p38 MAP kinase inhibitor, and SCIO-323, a second-generation p38 MAP kinase...

Preclinical efficacy, safety results of humanized anti-IL-4 antibody reported.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline Pharmaceutical recently published results of preclinical safety and efficacy trials of its humanized monoclonal antibody, dubbed pascolizumab. T.K. Hart, of GlaxoSmithKline...

Nasal immunization with heat shock proteins has therapeutic potential.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Results of a study in mice suggest nasal immunization with heat shock proteins could be a new approach to treating atherosclerosis. According to researchers, "Increasing evidence supports the...

High-dose IL-12 lethal to mice after allogeneic BMT.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Results of a study in mice have researchers thinking interleukin-12 (IL-12) application after allogenic bone marrow transplantation (allo-BMT) may not be a beneficial strategy. "T lymphocytes and...

New method could overcome drug resistance in cancer, infectious diseases.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced the issuance of United States Patent No. 6,468,530, which covers a method of treatment that uses conjugated polyspecific antibodies, or antibodies that bind to more...

Hyporesponsiveness after intratracheal delivery of alloantigen studied in mice.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Researchers in Japan have determined that, in mice, the B7/CTLA4 pathway is key for generating regulatory cells after intratracheal delivery of alloantigen. Y. Akiyama and colleagues, Teikyo...

T-cell tolerance induction by gene therapy studied.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Results of a recent study led researchers to conclude that "induction of tolerance in molecular chimeras requires expression of the retrovirally transduced allogeneic MHC Ag [antigens] on the surface...

Company to build biotechnology manufacturing plant in Puerto Rico.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced plans to build an approximately $350 million biotechnology manufacturing plant in Barceloneta, Puerto Rico. This plant, in addition to the company's recent...

Study: Pregabalin significantly improves pain in fibromyalgia patients.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc.'s, pregabalin was shown to provide improvement of pain in patients with fibromyalgia, according to data presented at the annual meeting of the American College of Rheumatology. ...

Results in diabetic foot infection study presented at meeting.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Data indicate that Zyvox (linezolid injection, tablets and for oral suspension) was as effective as two standard therapies in treating diabetic foot infections caused by Gram-positive bacteria such as...

Dartmouth receives $7.2 million grant to study new ways to tackle infections.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Dartmouth Medical School researchers are exploring the role sex hormones play in the body's rapid-response protection system through a National Institutes of Health grant for collaboration that could...

Distinct mechanisms of intestinal priming lead to cross-protection.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- A study of the mechanisms of immunological cross-protection has shown that intestinal priming promotes protection of the upper and lower respiratory tracts through distinct mechanisms. "A main...

Study: Memory CD8+ T cells are more resistant to apoptosis than naive cells.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Emory University vaccine researchers have demonstrated, in mice, that naive and memory CD8+ T cells have differing sensitivities to apoptosis. They think their findings may be applicable to designing...

Additional nutrients improve immune response to influenza vaccination in the elderly.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Elderly adults who took a complete nutritional supplement for 7 months mounted stronger antibody responses to influenza immunization compared with...

Nondepleting anti-CD4 + soluble interleukin-1 receptor improve graft survival.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- According to a recent study from England, "Successful islet transplantation in type 1 diabetes requires tolerance induction of both allo- and autoreactive T-cell responses. Monoclonal antibodies...

Cell fusion vaccine approach being tested.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Genzyme Molecular Oncology (GZMO) launched a new clinical trial in kidney cancer that uses an innovative vaccine made from combining the patient's own cancer cells with powerful, immune-stimulating...

Therapeutic polyvalent vaccine prolongs overall survival.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Canvaxin, a therapeutic polyvalent vaccine (PV), has been shown to significantly improve overall survival of patients with metastatic melanoma. The aim of D.L. Morton and colleagues, St. John's...

Psoriasis drug market to reach $3.9 billion in 2011.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that the psoriasis drug market will reach $3.9 billion in 2011. A major factor in growth of the market, especially in the first half of the 2001-2011 forecast...

Research suggests that treatment with infliximab may inhibit joint destruction.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- Patients with early rheumatoid arthritis (ERA) treated with Remicade (infliximab), in combination with methotrexate, appeared to experience greater inhibition of joint destruction and clinical...

B27 tolerance can be subverted by Chlamydia trachomatis.
December 11, 2002... 2002 DEC 11 - (NewsRx.com & NewsRx.net) -- According to arthritis researchers in Canada, "There is a strong association between seronegative arthritis and HLA B27, but it is still unresolved whether the contribution of B27 to disease...

Researcher summarizes the promise of dendritic cells.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- In a new report, Jacques Banchereau, PhD, director of the Baylor Institute for Immunology Research in Dallas, summarizes the current status of knowledge of dendritic cells, a class of white blood cells...

New compound as effective as current best treatment in preliminary study.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Researchers have tested a new treatment for psoriasis which appears to directly affect the immune cells in the skin of patients with this disorder. In this preliminary study, the treatment appears...

New treatment approach focuses on causes rather than symptoms.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Authors of a U.K. study suggest that targeting the underlying cause of asthma - rather than treating symptoms of the disorder - could be more effective in reducing severe asthma attacks. ...

Treatment helped reduce dose of inhaled corticosteroids while maintaining disease control.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- An asthma treatment that contains both an inhaled long-acting bronchodilator and an inhaled corticosteroid was as effective at providing overall asthma control as more than double the dose of the...

Versatile immunosuppressant drug may have a new role in radiotherapy.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- U.S. researchers have discovered that rapamycin, a drug developed as an immunosuppressant and now being used in cardiovascular stents and also being tested as a chemotherapy agent to prevent tumor cell...

Study: Patients remain on infliximab therapy longer than those on etanercept.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Patients with immune-mediated inflammatory disorders who are treated with infliximab (marketed as Remicade) are twice as likely to remain on therapy as those treated with etanercept (marketed as...

ACAAI launches national patient education campaign.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- The American College of Allergy, Asthma and Immunology (ACAAI) announced the roll-out of a Get Smart About Allergies national education campaign. In response to growing evidence that allergies...

States unite to reduce national threat of antibiotic resistance.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Healthcare leaders from over 30 states recently gathered in Sacramento, California, looking for answers to the national epidemic of antibiotic resistance - a growing problem preventing antibiotic...

Dr. John Padfield named nonexecutive chairman of the board.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Lorantis, Ltd., an immunology drug discovery company, announced the appointment of Dr. John Padfield as nonexecutive chairman of the board of directors. Padfield has been CEO of Amersham Health, a...

Big sample of U.S patients suffers from moderate-to-severe disease.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- In a cross-sectional, random-dial telephone survey of more than 42,000 households in the U.S., researchers found that the majority of the population with asthma experiences moderate to severe...

Patients at increased risk of attack during travel.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Travelers with asthma who use bronchodilators frequently before travel or participating in high-altitude hiking are at an increased risk of having an asthma attack, finds a new study. Asthma is...

Recombinant alpha 1-antitrypsin moves to clinic for dermatology applications.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences (TSX:PLI) and Arriva Pharmaceuticals, Inc., announced that their joint venture (JV), Arriva-ProMetic Inc, has received approval from the United States Food and Drug...

Strong results from Australian cancer vaccine trials.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology, Ltd. (AustCancer) (ACU) has announced achievement of a major milestone in phase Ib/IIa clinical trials of its Pentrix anticancer vaccine at St Vincent's Hospital, Sydney....

Carcinoembryonic antigen expressed by head and neck cancer tumors.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Many head and neck tumors were found to express human carcinoembryonic antigen (CEA), providing a potential target for vaccine therapy of head and...

Research offers new hope for those with scleroderma.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Research presented at the American College of Rheumatology meeting in New Orleans indicates that a new treatment option may offer a renewed quality of life for people with scleroderma. A...

Recombinant antibody Fab blocks HCV adsorption to susceptible cells in vitro.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Researchers in Japan demonstrated in vitro that recombinant antibody Fabs they developed block adsorption of hepatitis C virus by susceptible cells. "Antibodies against hypervariable region 1...

Study: Remune antigen with CpG ODN may offer HIV protection.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNRD) announced the final results of a study at McMaster University Health Sciences Centre suggesting that use of Remune antigen in combination with oligonucleotides...

Vaccine and immunotherapy adjuvant technology presented at IDD conference.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- PRIMABioMed, Ltd., a cancer and immunotherapy research and therapeutic development company, presented its vaccine and immunotherapy adjuvant technology, named DCtag, at the recent Innovative Drug...

Cancer-focused biotech company initiates phase I trial of TAPET with immune system modulation.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) announced that it had initiated a new phase I trial of TAPET VNP20009, its Salmonella bacteria anticancer vector, in patients with advanced solid tumors or lymphomas....

Therion Biologics licenses ICAM-1.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Therion Biologics Corp. has entered into a nonexclusive license agreement with Boehringer Ingelheim Pharmaceuticals, Inc., the U.S. subsidiary of the Boehringer Ingelheim group of companies, for the...

Personalized vaccine being tested.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- New York Weill Cornell Medical Center of New York-Presbyterian Hospital is currently seeking patients for a nationwide, multicenter clinical research trial to explore the benefits of a unique vaccine...

Research: Acetaminophen most cost-effective treatment for osteoarthritis pain.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Research presented at the American College of Rheumatology's (ACR) annual scientific meeting suggests that acetaminophen should be the initial therapy for the treatment of osteoarthritis (OA) pain...

U.S. FDA approves IND filing for Humax-Cd4.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that the U.S. Food and Drug Administration (FDA) had approved the investigational new drug (IND) filing for HuMax-CD4 for psoriasis and the initiation of a phase IIb study. ...

Study: Inner-city asthma intervention programs are cost-effective.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- Using social workers to educate inner-city children on controlling their asthma is a cost-effective way to reduce the number of days children exhibit asthma symptoms, according to a study. ...

Arthritis cells rely on transcription factor Stat3 for survival.
December 18, 2002... 2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Research conducted in the United States suggests the transcription factor Stat3 encourages the growth of cells associated with rheumatoid arthritis (RA). ...

Researchers discuss advances in treatment.
December 25, 2002... 2002 DEC 25 - (NewsRx.com & NewsRx.net) -- Asthmatics are known to suffer from highly sensitive airways that are inflamed and excessively constricted. In a new study, Dr. Peter K. Jeffery (Royal Brompton Hospital, London) and colleagues...